The Pharmaceutical Benefits Advisory Committee has provided a submission to the Senate Inquiry on the availability of new, innovative and specialist cancer drugs in Australia.

For more details, go to: http://www.pbs.gov.au/info/industry/listing/elements/pbac-meetings/pbac-submission-senate-inquiry